<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Astrocytes in Wilson Disease</th>
</tr>
<tr>
<td class="label">Category</td>
<td>Hepatic Encephalopathy / Metal Metabolism Disorders</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Basal ganglia, cerebral cortex, cerebellum</td>
</tr>
<tr>
<td class="label">Cell Type</td>
<td>Protoplasmic astrocytes</td>
</tr>
<tr>
<td class="label">Key Gene</td>
<td>ATP7B (copper-transporting ATPase)</td>
</tr>
<tr>
<td class="label">Inheritance</td>
<td>Autosomal recessive</td>
</tr>
<tr>
<td class="label">Prevalence</td>
<td>~1:30,000 worldwide</td>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:4042028](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4042028)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:4042028](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4042028)</td>
</tr>
<tr>
<td class="label">Function</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Copper uptake</td>
<td>CTR1 (SLC31A1) transporter</td>
</tr>
<tr>
<td class="label">Copper storage</td>
<td>Metallothionein binding</td>
</tr>
<tr>
<td c
<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Astrocytes in Wilson Disease</th>
</tr>
<tr>
<td class="label">Category</td>
<td>Hepatic Encephalopathy / Metal Metabolism Disorders</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Basal ganglia, cerebral cortex, cerebellum</td>
</tr>
<tr>
<td class="label">Cell Type</td>
<td>Protoplasmic astrocytes</td>
</tr>
<tr>
<td class="label">Key Gene</td>
<td>ATP7B (copper-transporting ATPase)</td>
</tr>
<tr>
<td class="label">Inheritance</td>
<td>Autosomal recessive</td>
</tr>
<tr>
<td class="label">Prevalence</td>
<td>~1:30,000 worldwide</td>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:4042028](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4042028)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:4042028](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4042028)</td>
</tr>
<tr>
<td class="label">Function</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Copper uptake</td>
<td>CTR1 (SLC31A1) transporter</td>
</tr>
<tr>
<td class="label">Copper storage</td>
<td>Metallothionein binding</td>
</tr>
<tr>
<td class="label">Copper export</td>
<td>ATP7A (in neurons), ATP7B (in astrocytes)</td>
</tr>
<tr>
<td class="label">Detoxification</td>
<td>Ceruloplasmin synthesis</td>
</tr>
<tr>
<td class="label">Effect</td>
<td>Consequence</td>
</tr>
<tr>
<td class="label">Complex IV inhibition</td>
<td>Reduced ATP production</td>
</tr>
<tr>
<td class="label">ROS generation</td>
<td>Oxidative damage</td>
</tr>
<tr>
<td class="label">Calcium dysregulation</td>
<td>Cellular stress</td>
</tr>
<tr>
<td class="label">Apoptosis induction</td>
<td>Cell death</td>
</tr>
<tr>
<td class="label">Structure</td>
<td>Effect</td>
</tr>
<tr>
<td class="label">Putamen</td>
<td>Degeneration, cavitation</td>
</tr>
<tr>
<td class="label">Globus pallidus</td>
<td>Copper accumulation, necrosis</td>
</tr>
<tr>
<td class="label">Caudate</td>
<td>Atrophy</td>
</tr>
<tr>
<td class="label">Subthalamic nucleus</td>
<td>Dyskinesias</td>
</tr>
<tr>
<td class="label">Region</td>
<td>T2 Signal</td>
</tr>
<tr>
<td class="label">Putamen</td>
<td>Increased</td>
</tr>
<tr>
<td class="label">Globus pallidus</td>
<td>Decreased</td>
</tr>
<tr>
<td class="label">Thalamus</td>
<td>Variable</td>
</tr>
<tr>
<td class="label">Brainstem</td>
<td>Increased</td>
</tr>
<tr>
<td class="label">White matter</td>
<td>Increased</td>
</tr>
<tr>
<td class="label">Drug</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Penicillamine</td>
<td>Cu⁺ chelation</td>
</tr>
<tr>
<td class="label">Trientine</td>
<td>Cu⁺ chelation</td>
</tr>
<tr>
<td class="label">Tetrathiomolybdate</td>
<td>Blocks copper absorption</td>
</tr>
</table>
Wilson Disease (hepatolenticular degeneration) is an autosomal recessive disorder caused by mutations in the ATP7B gene, leading to impaired copper excretion from hepatocytes. Astrocytes, as key copper-handling cells in the brain, play a central role in the neurological manifestations of Wilson Disease. This page examines how astrocyte dysfunction contributes to neurodegeneration in this disorder. [@wilson1912]
Astrocytes are critical for brain copper balance:
Wilson Disease results from ATP7B dysfunction:
Copper catalyzes reactive oxygen species formation:
Cu⁺ + O₂ → Cu²⁺ + O₂⁻ (superoxide)
Cu²⁺ + H₂O₂ → Cu⁺ + •OH + OH⁻ (hydroxyl radical)
Consequences:
Copper accumulation impairs astrocyte mitochondria:
In Wilson Disease:
The basal ganglia are particularly vulnerable:
The study of Astrocytes In Wilson Disease has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
From the [SciDEX Exchange](/exchange) — scored by multi-agent debate
Related Analyses:
The following diagram shows the key molecular relationships involving Astrocytes in Wilson Disease discovered through SciDEX knowledge graph analysis: